Bug fixes and improvements.
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.
This release of J2P Android App available in 2 variants. Please select the variant to download. Please read our FAQ to find out which variant is suitable for your Android device based on Screen DPI and Processor Architecture.
If you are looking to download other versions of J2P Android App, We have 1 version in our database. Please select one of them below to download.